207 related articles for article (PubMed ID: 16920323)
1. Development and validation of a stability-indicating analytical method for the quantitation of oxytocin in pharmaceutical dosage forms.
Chaibva FA; Walker RB
J Pharm Biomed Anal; 2007 Jan; 43(1):179-85. PubMed ID: 16920323
[TBL] [Abstract][Full Text] [Related]
2. Development and validation of a stability-indicating high performance liquid chromatographic (HPLC) assay for biperiden in bulk form and pharmaceutical dosage forms.
Mohammadi A; Mehramizi A; Moghaddam FA; Jabarian LE; Pourfarzib M; Kashani HN
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jul; 854(1-2):152-7. PubMed ID: 17466605
[TBL] [Abstract][Full Text] [Related]
3. A stability-indicating HPLC method for the determination of glucosamine in pharmaceutical formulations.
Shao Y; Alluri R; Mummert M; Koetter U; Lech S
J Pharm Biomed Anal; 2004 May; 35(3):625-31. PubMed ID: 15137989
[TBL] [Abstract][Full Text] [Related]
4. Stability indicating validated HPLC method for quantification of levothyroxine with eight degradation peaks in the presence of excipients.
Shah RB; Bryant A; Collier J; Habib MJ; Khan MA
Int J Pharm; 2008 Aug; 360(1-2):77-82. PubMed ID: 18524511
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a HPLC-UV method for the determination in didanosine tablets.
de Oliveira AM; Löwen TC; Cabral LM; dos Santos EM; Rodrigues CR; Castro HC; dos Santos TC
J Pharm Biomed Anal; 2005 Jul; 38(4):751-6. PubMed ID: 15967304
[TBL] [Abstract][Full Text] [Related]
6. A stability-indicating HPLC assay for metronidazole benzoate.
Bempong DK; Manning RG; Mirza T; Bhattacharyya L
J Pharm Biomed Anal; 2005 Jul; 38(4):776-80. PubMed ID: 15967308
[TBL] [Abstract][Full Text] [Related]
7. A validated RP-HPLC method for the determination of mosapride citrate in bulk drug samples and pharmaceutical formulations.
Krishnaiah YS; Murthy TK; Sankar DG; Satyanarayana V
Pharmazie; 2002 Dec; 57(12):814-6. PubMed ID: 12561242
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of a HPLC method for the analysis of promethazine hydrochloride in hot-melt extruded dosage forms.
Thumma S; Zhang SQ; Repka MA
Pharmazie; 2008 Aug; 63(8):562-7. PubMed ID: 18771002
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of a HPLC method for the determination of cetirizine in pharmaceutical dosage forms.
Paw B; Misztal G; Hopkała H; Drozd J
Pharmazie; 2002 May; 57(5):313-5. PubMed ID: 12061254
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of a gradient HPLC method for the determination of clindamycin and related compounds in a novel tablet formulation.
Platzer DJ; White BA
J Pharm Biomed Anal; 2006 Apr; 41(1):84-8. PubMed ID: 16298506
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of a stability-indicating method for the quantitation of Paclitaxel in pharmaceutical dosage forms.
Mohammadi A; Esmaeili F; Dinarvand R; Atyabi F; Walker RB
J Chromatogr Sci; 2009 Aug; 47(7):599-604. PubMed ID: 19772735
[TBL] [Abstract][Full Text] [Related]
12. A stability-indicating high performance liquid chromatographic assay for the determination of orlistat in capsules.
Mohammadi A; Haririan I; Rezanour N; Ghiasi L; Walker RB
J Chromatogr A; 2006 May; 1116(1-2):153-7. PubMed ID: 16603170
[TBL] [Abstract][Full Text] [Related]
13. Nateglinide quantification in rabbit plasma by HPLC: optimization and application to pharmacokinetic study.
Sankalia JM; Sankalia MG; Sutariya VB; Mashru RC
J Pharm Biomed Anal; 2007 May; 44(1):196-204. PubMed ID: 17398055
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of a stability-indicating HPLC-UV method for the determination of alizapride and its degradation products.
Tamaro I; Aprile S; Giovenzana GB; Grosa G
J Pharm Biomed Anal; 2010 Apr; 51(5):1024-31. PubMed ID: 19962264
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of a rapid RP-HPLC method for the determination of cetirizine or fexofenadine with pseudoephedrine in binary pharmaceutical dosage forms.
Karakuş S; Küçükgüzel I; Küçükgüzel SG
J Pharm Biomed Anal; 2008 Jan; 46(2):295-302. PubMed ID: 18054459
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of a stability indicating RP-HPLC method for the simultaneous determination of related substances of albuterol sulfate and ipratropium bromide in nasal solution.
Kasawar GB; Farooqui M
J Pharm Biomed Anal; 2010 May; 52(1):19-29. PubMed ID: 20045275
[TBL] [Abstract][Full Text] [Related]
17. Determination of cetirizine dihydrochloride, related impurities and preservatives in oral solution and tablet dosage forms using HPLC.
Jaber AM; Al Sherife HA; Al Omari MM; Badwan AA
J Pharm Biomed Anal; 2004 Oct; 36(2):341-50. PubMed ID: 15496327
[TBL] [Abstract][Full Text] [Related]
18. Quantitative determination of anti-tumor agent bis(4-fluorobenzyl)trisulfide, fluorapacin and its pharmaceutical preparation by high-performance liquid chromatography.
Bao Y; He Y; Xu X; Mo X; Xu X; Wang X; An H
J Pharm Biomed Anal; 2008 Jan; 46(1):206-10. PubMed ID: 17964749
[TBL] [Abstract][Full Text] [Related]
19. A validated stability-indicating LC method for acetazolamide in the presence of degradation products and its process-related impurities.
Srinivasu P; Subbarao DV; Vegesna RV; Sudhakar Babu K
J Pharm Biomed Anal; 2010 May; 52(1):142-8. PubMed ID: 20053517
[TBL] [Abstract][Full Text] [Related]
20. Determination of tramadol hydrochloride in ampoule dosage forms by using UV spectrophotometric and HPLC-DAD methods in methanol and water media.
Küçük A; Kadioğlu Y
Farmaco; 2005 Feb; 60(2):163-9. PubMed ID: 15752475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
